Comparison of PEF vs. FEV 1 Endpoints in Trials With Tiotropium in Adults and Adolescents With Moderate or Severe Symptomatic Asthma
Journal of Allergy and Clinical Immunology - United States
doi 10.1016/j.jaci.2017.12.668
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2018
Authors
Publisher
Elsevier BV